BINEX (Korea) Today
| 053030 Stock | KRW 16,670 100.00 0.60% |
Performance0 of 100
| Odds Of DistressLess than 9
|
BINEX is trading at 16670.00 as of the 28th of November 2024, a 0.60 percent increase since the beginning of the trading day. The stock's open price was 16570.0. BINEX has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for BINEX Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company was founded in 1957 and is based in Incheon, South Korea. Binex is traded on Korean Securities Dealers Automated Quotations in South Korea. The company has 31.19 M outstanding shares. More on BINEX Co
Moving together with BINEX Stock
Moving against BINEX Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BINEX Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BINEX's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BINEX or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Hyeok Lee |
| Business Concentration | Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
BINEX Co (053030) is traded on KOSDAQ in Korea and employs 503 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 343.38 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BINEX's market, we take the total number of its shares issued and multiply it by BINEX's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BINEX operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 31.19 M outstanding shares.
BINEX Co has accumulated about 50.08 B in cash with 28.07 B of positive cash flow from operations.
Check BINEX Probability Of Bankruptcy
Ownership AllocationBINEX holds a total of 31.19 Million outstanding shares. BINEX Co shows 11.07 percent of its outstanding shares held by insiders and 7.02 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BINEX Ownership Details
BINEX Risk Profiles
Although BINEX's alpha and beta are two of the key measurements used to evaluate BINEX's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.42 | |||
| Standard Deviation | 4.93 | |||
| Variance | 24.33 | |||
| Risk Adjusted Performance | (0.05) |
BINEX Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BINEX without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
BINEX Corporate Directors
| Yin Oh | Non-Executive Independent Director | Profile | |
| Taizan Kawakami | Director | Profile | |
| Shigeki Yamauchi | Director | Profile | |
| Jun Park | Managing Director | Profile |
Other Information on Investing in BINEX Stock
BINEX financial ratios help investors to determine whether BINEX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BINEX with respect to the benefits of owning BINEX security.